Pharma Deals Review, Vol 2008, No 96 (2008)

Font Size:  Small  Medium  Large

Alnylam and Takeda Form RNAi Partnership

Helen Scrutton

Abstract


Japanese company, Takeda Pharmaceutical, has strengthened it oncology pipeline through this RNAi alliance with US biotech, Alnylam Pharmaceuticals.

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.